Sen. Al Franken, D-Minn., on Friday held a conference with medical-device companies in Minnesota to discuss their views on the changes proposed by the FDA to the 510(k) process for clearing medical products. Franken is seeking a meeting with FDA Commissioner Margaret Hamburg in September to relay the industry's concerns about the changes in an effort to "continue to foster medical innovation and protect patient safety."

Full Story:
Hill, The

Related Summaries